At the news
? NEUTRALIMPACT 3/10 144 filed Nov 10, 2026 at 16:16 ET
Richard D. Francis, an officer of Teva, filed a Form 144 notice of intent to sell 250,000 ordinary shares, with an estimated aggregate market value of $10,742,500 based on a filing price of approximately $42.97 per share. The shares were acquired through vesting of restricted share units between February 2024 and March 2025 as compensation. The sale is planned for or after November 10, 2026, and represents a notable insider sale relative to the company's $49.7B market cap.
- Insider Richard D. Francis (officer) filed Form 144 to sell 250,000 ordinary shares.
- Estimated aggregate market value of the proposed sale is $10,742,500.
- Shares were acquired through vesting of restricted share units from February 2024 to March 2025.
- The filing date is November 10, 2026; the proposed sale date is also November 10, 2026.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access